Foghorn Therapeutics Inc. (FHTX) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Foghorn Therapeutics Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Foghorn Therapeutics Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$497 M, a 23% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$497 M -$93 M -23% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$472 M -$98.4 M -26.4% Dec 31, 2023 10-Q 2024-05-06
Q3 2023 -$447 M -$103 M -30% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$433 M -$115 M -36% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$404 M -$112 M -38.6% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$373 M -$109 M -41.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$344 M -$109 M -46.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$318 M -$109 M -52.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$291 M -$105 M -56.6% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$264 M -$101 M -62.2% Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$235 M -$92.9 M -65.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$209 M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$186 M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 -$163 M -$68.8 M -73.1% Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 -$142 M Sep 30, 2020 10-Q 2020-12-04
Q4 2019 -$94.1 M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.